STABLE ANTI-CLEVER-1 ANTIBODY FORMULATION

The invention relates to stable formulations comprising an anti-CLEVER-1 antibody or antigen binding fragments thereof. The present invention further relates to stable formulations of an anti-CLEVER-1 antibody or antigen binding fragments thereof for use in treatment of various diseases and disorder...

Full description

Saved in:
Bibliographic Details
Main Authors Mandelin, Jami, Vainio, Marita
Format Patent
LanguageEnglish
Finnish
Swedish
Published 31.01.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention relates to stable formulations comprising an anti-CLEVER-1 antibody or antigen binding fragments thereof. The present invention further relates to stable formulations of an anti-CLEVER-1 antibody or antigen binding fragments thereof for use in treatment of various diseases and disorders. Keksintö koskee stabiileja koostumuksia, jotka käsittävät anti-CLEVER-1-vasta-ainetta tai sen antigeeniä sitovia fragmentteja. Esillä oleva keksintö koskee lisäksi antiCLEVER-1-vasta-aineen tai sen antigeeniä sitovien fragmenttien stabiileja koostumuksia käytettäväksi eri tautien ja häiriötilojen hoitoon.
Bibliography:Application Number: FI20200005624